VanEck Associates
RGEN icon

VanEck Associates’s Repligen RGEN Stock Holding History

VanEck Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$744K Sell
6,533
-29,983
-82% -$4.19M ﹤0.01% 1124
2025
Q4 		$5.98M Sell
36,516
-3,231
-8% -$506K ﹤0.01% 729
2025
Q3 		$5.31M Sell
39,747
-3,734
-9% -$454K ﹤0.01% 745
2025
Q2 		$5.41M Sell
43,481
-734
-2% -$93.4K 0.01% 698
2025
Q1 		$5.63M Buy
44,215
+1,989
+5% +$306K 0.01% 664
2024
Q4 		$6.08M Buy
42,226
+3,066
+8% +$440K 0.01% 614
2024
Q3 		$5.38M Sell
39,160
-6,025
-13% -$864K 0.01% 611
2024
Q2 		$5.7M Buy
45,185
+404
+0.9% +$63.3K 0.01% 541
2024
Q1 		$8.24M Sell
44,781
-1,755
-4% -$334K 0.01% 455
2023
Q4 		$8.37M Sell
46,536
-8,016
-15% -$1.25M 0.02% 416
2023
Q3 		$8.68M Sell
54,552
-1,611
-3% -$263K 0.02% 368
2023
Q2 		$7.94M Sell
56,163
-4,644
-8% -$745K 0.02% 394
2023
Q1 		$10.2M Sell
60,807
-4,206
-6% -$750K 0.02% 345
2022
Q4 		$11M Buy
65,013
+16,660
+34% +$3.02M 0.03% 319
2022
Q3 		$9.05M Buy
48,353
+42,506
+727% +$8.96M 0.03% 329
2022
Q2 		$950K Sell
5,847
-648
-10% -$102K ﹤0.01% 801
2022
Q1 		$1.22M Buy
6,495
+2,422
+59% +$460K ﹤0.01% 799
2021
Q4 		$1.08M Buy
4,073
+636
+19% +$171K ﹤0.01% 832
2021
Q3 		$993K Sell
3,437
-16
-0.5% -$4.11K ﹤0.01% 809
2021
Q2 		$689K Buy
3,453
+137
+4% +$26.6K ﹤0.01% 867
2021
Q1 		$645K Buy
+3,316
New +$680K ﹤0.01% 813

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VanEck Associates's RGEN Position: Q1 2026 in Review

VanEck Associates reduced its Repligen (RGEN) stake by 82% in Q1 2026, selling an estimated $4.19M and leaving 6,533 shares worth $744K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

VanEck Associates first reported a position in RGEN in Q1 2021 and has held it in 21 quarters since. The position peaked at $11M in Q4 2022. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • VanEck Associates held 6,533 shares of Repligen worth $744K as of Q1 2026.
  • VanEck Associates sold 29,983 Repligen shares in Q1 2026, an estimated $4.19M.
  • Repligen made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1124 holding.
  • VanEck Associates first reported a position in Repligen in Q1 2021 and has held it in 21 quarters since.
  • VanEck Associates's Repligen position peaked at $11M in Q4 2022.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.